CHM — Chimeric Therapeutics Balance Sheet
0.000.00%
Last trade - 00:00- AU$21.05m
- AU$20.16m
Annual balance sheet for Chimeric Therapeutics, fiscal year end - June 30th, AUD millions except per share, conversion factor applied.
2020 June 30th | 2021 June 30th | 2022 June 30th | 2023 June 30th | |
|---|---|---|---|---|
| Period Length: | — | — | — | — |
| Source: | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final |
| Cash | ||||
| Cash and Equivalents | ||||
| Cash and Short Term Investments | 0 | 22.4 | 18.4 | 2.36 |
| Net Total Accounts Receivable | ||||
| Net Total Receivables | — | 0.024 | 2.66 | 7.07 |
| Total Other Current Assets | ||||
| Total Current Assets | 0 | 22.7 | 21.2 | 9.47 |
| Net Property, Plant And Equipment | — | 0.014 | 0.016 | 0.006 |
| Net Intangible Assets | ||||
| Long Term Investments | ||||
| Total Assets | 0 | 36.5 | 34.9 | 22.5 |
| Accounts Payable | ||||
| Payable / Accrued | ||||
| Accrued Expenses | ||||
| Notes Payable / Short Term Debt | ||||
| Total Other Current Liabilities | ||||
| Total Current Liabilities | 0.064 | 7.35 | 9.02 | 14.4 |
| Long Term Debt | ||||
| Total Long Term Debt | ||||
| Total Debt | ||||
| Total Other Liabilities | ||||
| Total Liabilities | 0.064 | 11.4 | 9.17 | 16.4 |
| Common Stock | ||||
| Retained Earnings (Accumulated Deficit) | ||||
| Total Equity | -0.064 | 25.1 | 25.7 | 6.08 |
| Total Liabilities & Shareholders' Equity | 0 | 36.5 | 34.9 | 22.5 |
| Total Common Shares Outstanding |